- Report
- September 2026
- 183 Pages
Global
From €3222EUR$3,545USD£2,771GBP
€3580EUR$3,939USD£3,079GBP
- Report
- September 2026
- 263 Pages
Global
From €5318EUR$5,850USD£4,572GBP
- Report
- February 2026
- 250 Pages
Global
From €4081EUR$4,490USD£3,509GBP
- Report
- August 2026
- 160 Pages
Global
From €3018EUR$3,320USD£2,595GBP
€3772EUR$4,150USD£3,243GBP
- Report
- September 2026
- 276 Pages
Global
From €5318EUR$5,850USD£4,572GBP
- Report
- March 2026
- 114 Pages
Global
From €3177EUR$3,495USD£2,731GBP
- Report
- September 2026
- 187 Pages
Global
From €3222EUR$3,545USD£2,771GBP
€3580EUR$3,939USD£3,079GBP
- Report
- February 2026
- 250 Pages
Global
From €4081EUR$4,490USD£3,509GBP
- Report
- July 2025
Global
From €4454EUR$4,900USD£3,830GBP
- Report
- November 2023
- 183 Pages
Global
From €4090EUR$4,500USD£3,517GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1363EUR$1,500USD£1,172GBP
- Report
- June 2024
- 200 Pages
Global
From €7226EUR$7,950USD£6,213GBP
- Report
- May 2023
- 160 Pages
Global
From €4499EUR$4,949USD£3,868GBP
- Report
- May 2024
- 135 Pages
Global
From €2726EUR$2,999USD£2,344GBP
€3635EUR$3,999USD£3,125GBP
- Report
- July 2025
- 250 Pages
Global
From €4540EUR$4,995USD£3,904GBP
- Report
- June 2023
- 173 Pages
Global
From €3272EUR$3,600USD£2,814GBP
- Report
- June 2023
- 82 Pages
Europe
From €1363EUR$1,500USD£1,172GBP
- Report
- June 2023
- 81 Pages
Africa, Middle East
From €1363EUR$1,500USD£1,172GBP
- Report
- June 2023
- 83 Pages
Asia Pacific
From €1363EUR$1,500USD£1,172GBP
- Report
- June 2023
- 76 Pages
North America
From €1363EUR$1,500USD£1,172GBP

The Fibromyalgia Drug market is a subset of the Immune Disorders Drugs market, which includes treatments for a variety of conditions related to the immune system. Fibromyalgia is a chronic disorder characterized by widespread musculoskeletal pain, fatigue, and tenderness in localized areas. Fibromyalgia drugs are used to reduce pain, improve sleep, and reduce fatigue. Commonly prescribed drugs include antidepressants, anticonvulsants, and muscle relaxants. Other treatments include physical therapy, cognitive behavioral therapy, and lifestyle modifications.
The Fibromyalgia Drug market is highly competitive, with a number of companies offering treatments. Some of the major players in the market include Pfizer, Eli Lilly, Merck, and Novartis. Other companies include AbbVie, Allergan, and Teva Pharmaceuticals. Show Less Read more